Cardiovascular disease is the leading cause of mortality and significant morbidly among women in the United States. The frequent absence of antecedent symptoms, the potential for an initial fatal cardiac event and the limitations of currently available noninvasive diagnostic tests pose challenges to healthcare practitioners as they try to optimally risk stratify patients. Therefore, the purpose of this article is to discuss the accuracy of noninvasive tests for CAD diagnosis in women.
Kristine A. Scordo, PhD, RN, CS, ACNP Professor and Director, Acute Care Nurse Practitioner Program, Wright State University, and Acute Care Nurse Practitioner, Schuster Cardiology Associates, Dayton, Ohio.
Corresponding author Kristine A. Scordo, PhD, RN, CS, ACNP, Wright State University, College of Nursing, 120 University Hall, Dayton, OH 45435 (e-mail: email@example.com).